Award
Delivery Order #SPE2DR26FA7P7
Short-Term Delivery Order for Humira Syringes to Federal Agency
Buyer
Defense Logistics Agency
Award Amount
$2,198.97
Ceiling
$2,198.97
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 03, 2026
Identifier
SPE2DR26FA7P7
NAICS
424210
This award is a delivery order contract issued under a larger indefinite delivery vehicle with AmerisourceBergen Drug Corporation, a prominent pharmaceutical distributor specializing in medical product distribution. The contract procures Humira (adalimumab) 40 mg/0.4 ml syringes, vital for treating certain autoimmune diseases, reinforcing the agency's ongoing medical supply needs. The contract supports timely access to essential biological therapeutics, enhancing patient care within the federal health system. The scope includes the provision and delivery of the specified medication within a concise timeframe, ensuring rapid availability. This delivery order stems from a competitively acquired overarching contract vehicle facilitating pharmaceutical procurement. The contract period is notably brief, covering a single day, aligning with rapid fulfillment requirements. The award builds upon the existing long-term supply agreement with AmerisourceBergen established under a Federal Supply Schedule framework, highlighting continuity and reliability in pharmaceutical sourcing.
Description
4571003949!HUMIRA(CF) 40 MG/0.4 ML SYRINGS